0

Xstrahl in action: New Expansion Protocols Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in children. Despite intensive research in recent decades the prognosis for patients with metastatic or relapsed diseases has only [...]

0

User Spotlight: Just Skin Treatment Clinic uses the Xstrahl 100 for the treatment of skin cancer in Australia

The Xstrahl 100 is perfectly suited for the treatment of non-melanoma skin cancers, and with Australia recording skin cancer rates of 2 in every 3 adults, the need for an effective and versatile [...]

0

Unique Model Development For Precise Targeting Using SARRP

Radiation induced normal tissue damage and toxicity is sometimes an inevitable side effect when treating tumors with radiation therapy. Despite the technological advancements in imaging, [...]

0

Xstrahl participates in ASTRO 59th annual meeting

Xstrahl attended the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO) conference in San Diego, this September, the world’s largest meeting for the radiation [...]